Trump’s AG Pick Silent on Federal Cannabis Plans
US Attorney General nominee Pam Bondi has provided no clear indication of her planned approach to federal marijuana policy, offering identical responses to all cannabis-related inquiries during her confirmation process.
“If confirmed, I will give the matter careful consideration after consulting with appropriate Department officials,” Bondi said repeatedly in written responses to questions from the Senate Judiciary Committee.
The former Florida attorney general faced detailed inquiries about federal cannabis enforcement and regulation from Democratic Senators Cory Booker (N.J.) and Peter Welch (Vt.). Key issues included the Biden administration’s initiative to reclassify marijuana under the Controlled Substances Act and the future of federal enforcement in states with legal cannabis markets.
Her noncommittal stance appears at odds with President Trump’s recently expressed views on marijuana reform. On his social media platform Truth Social, Trump declared, “I believe it is time to end needless arrests and incarcerations of adults for small amounts of marijuana for personal use. We must also implement smart regulations, while providing access for adults, to safe, tested product.”
Bondi’s record on cannabis regulation during her 2011-2019 tenure as Florida’s top law enforcement official includes opposition to medical marijuana initiatives. Her office notably defended Florida’s prohibition on smoking medical cannabis, citing health concerns about secondhand smoke exposure.
Related: Trump Supports Marijuana Legalization in Florida … Kind Of?
The confirmation proceedings coincide with delays in federal marijuana rescheduling hearings, which have been postponed following concerns about communications between DEA officials and opponents of rescheduling.
The position of DEA administrator remains unfilled, with a former deputy administrator under consideration despite previous statements characterizing marijuana as a “gateway drug.”
Information for this story was found via the sources and companies mentioned. The author has no securities or affiliations related to the organizations discussed. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.
I don’t mind it , I guess. The problem is that they usually vape it so it’s not obvious until you start feeling dizzy , if you are allergic to it or have respiratory issues. I think it should be legal, only at home. Not on the streets, public transportation, airplanes, amtrak, . In NYS I went to Jason Bonhams Led Zeppelin experience and it was a drug Palace Theater. It’s hard to believe people drive on it . I must be 51 with asthma!!